Melinta Therapeutics Announces Proposed Offering of Common Stock

NEW HAVEN, Conn. , May 21, 2018 (GLOBE NEWSWIRE) — Melinta Therapeutics, Inc. (NASDAQ:MLNT), a commercial-stage company discovering, developing and commercializing novel antibiotics to treat serious bacterial infections, today announced that it has commenced an underwritten public offering of

READ FULL TEXT

Leave a Reply

Your email address will not be published.